Phillip Monk
Director Técnico/Científico/I+D en SYNAIRGEN PLC .
Fortuna: 32 910 $ al 30/04/2024
Cargos activos de Phillip Monk
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| SYNAIRGEN PLC | Director/Miembro de la Junta | 03/09/2009 | - |
| Director Técnico/Científico/I+D | 03/09/2009 | - | |
| Corporate Officer/Principal | 01/10/2006 | 03/09/2009 | |
Synairgen Research Ltd.
 Synairgen Research Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Synairgen Plc, Synairgen Research Ltd. is a British company that engages in respiratory biology and develops novel therapies. The company is based in Southampton, UK. Synairgen Research was founded in 2003. | Director/Miembro de la Junta | 03/09/2009 | - |
Historial de carrera de Phillip Monk
Antiguos cargos conocidos de Phillip Monk.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
MedImmune Ltd.
 MedImmune Ltd. BiotechnologyHealth Technology MedImmune Ltd. engages in research, development and exploitation of products in the field of molecular engineering. The company was founded on December 11, 1989 and is headquartered in Cambridge, the United Kingdom. | Corporate Officer/Principal | - | - |
Estadísticas
Internacional
| Reino Unido | 4 |
Operativa
| Director/Board Member | 2 |
| Corporate Officer/Principal | 2 |
| Chief Tech/Sci/R&D Officer | 1 |
Sectorial
| Health Technology | 3 |
| Commercial Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| SYNAIRGEN PLC | Health Technology |
| Empresas privadas | 2 |
|---|---|
MedImmune Ltd.
MedImmune Ltd. BiotechnologyHealth Technology MedImmune Ltd. engages in research, development and exploitation of products in the field of molecular engineering. The company was founded on December 11, 1989 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
Synairgen Research Ltd.
Synairgen Research Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Synairgen Plc, Synairgen Research Ltd. is a British company that engages in respiratory biology and develops novel therapies. The company is based in Southampton, UK. Synairgen Research was founded in 2003. | Commercial Services |
- Bolsa de valores
- Insiders
- Phillip Monk
- Experiencia